Grondhuis Palacios Lorena A, van Zanten Paul, den Ouden Marjolein E M, Krouwel Esmée M, Beck Jack J H, Reisman Yacov, Putter Hein, Pelger Rob C M, Elzevier Henk W, den Oudsten Brenda L
Department of Urology, Leiden University Medical Center, Leiden, the Netherlands.
Department of Urology, Leiden University Medical Center, Leiden, the Netherlands.
Urology. 2019 Dec;134:135-142. doi: 10.1016/j.urology.2019.08.041. Epub 2019 Sep 5.
To evaluate possible discrepancies between patients' expectations concerning sexual side effects related to prostate cancer treatment, based on the obtained information prior to treatment. Moreover, to determine if demographic or clinical factors may have an effect on the accuracy of patients' expectations concerning sexual side effects after treatment.
A multicenter, cross-sectional survey was performed among men treated with prostatectomy, brachytherapy, external-beam radiotherapy and/or hormonal therapy.
In total, 412 questionnaires were analyzed. Of men with sexual side effects after treatment, 1 in 3 (32.5%, n = 109) reported their complaints as worse than expected; significantly more often reported by men treated surgically (P = .001), men with a local stage tumor (P = .005) and by men with a lower prostate-specific antigen level at diagnosis (P = .046). It was significantly less often reported by men treated with radiotherapy combined with hormonal therapy (P = .031). Men who used brochures as an information source reported their sexual side effects significantly less often as worse than expected (P < .001).
One in three men with sexual side effects after prostate cancer treatment, experienced their complaints as worse than expected based on the obtained information prior to treatment. Men treated with radiotherapy combined with hormonal therapy indicated less discrepancy between expectations and developed sexual side effects, whereas prostatectomy, low stage tumor and low prostate-specific antigen level were associated with more discrepancy. Brochures should be administered additionally to verbal information to improve patients' understanding of possible sexual side effects and to enhance the accuracy of patients' expectations.
根据治疗前获取的信息,评估前列腺癌治疗相关的性副作用方面患者期望可能存在的差异。此外,确定人口统计学或临床因素是否可能对患者治疗后性副作用期望的准确性产生影响。
对接受前列腺切除术、近距离放射治疗、外照射放疗和/或激素治疗的男性进行了一项多中心横断面调查。
共分析了412份问卷。在治疗后出现性副作用的男性中,三分之一(32.5%,n = 109)报告其症状比预期更严重;接受手术治疗的男性(P = 0.001)、局部肿瘤分期的男性(P = 0.005)以及诊断时前列腺特异性抗原水平较低的男性(P = 0.046)报告症状比预期更严重的情况明显更多。接受放疗联合激素治疗的男性报告这种情况的比例明显更低(P = 0.031)。将宣传册作为信息来源的男性报告其性副作用比预期更严重的情况明显更少(P < 0.001)。
前列腺癌治疗后出现性副作用的男性中,三分之一的人根据治疗前获取的信息,感觉其症状比预期更严重。接受放疗联合激素治疗的男性表明期望与出现的性副作用之间的差异较小,而前列腺切除术、低分期肿瘤和低前列腺特异性抗原水平与更大的差异相关。除了口头信息外,还应提供宣传册,以提高患者对可能出现的性副作用的理解,并提高患者期望的准确性。